ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transplantation - Heart

November 17, 2022
Researchers continue to report findings from the first genetically modified pig heart transplant into a human ten months after the surgery. Their latest study found unexpected electrocardiogram results in the patient, which the authors say did not contribute to heart failure.
November 4, 2022
New data, to be presented at the American Heart Association’s annual meeting November 5-7, 2022, shows that hearts from COVID-19 positive donors may be as safe to transplant as those from donors without the virus.
October 21, 2022
A new study shows that white heart transplant patients are twice as likely to receive a heart transplant or ventricular assist device as Black heart transplant patients, perpetuating existing inequalities in healthcare access. Experts emphasize that this is due to differences in education and access, not biological determinants.
September 30, 2022
This retrospective review compares the outcomes of heart failure patients who used continuous-flow left ventricular device (CF-LVAD) support with patients listed as primary transplant candidates at the same center. The results showed that CF-LVAD patients had excellent outcomes regardless of how long they were on the waitlist.
September 15, 2022
Over the past three decades, more than 76,000 heart transplantations have been performed. This study evaluated trends and outcomes of patients who underwent the procedure to treat peripartum cardiomyopathy (PPCM)—a disease limited to female patients—the frequency of which increased over the study period.
July 20, 2022
A year ago, a twelve-year-old girl became the youngest person in Canada undergo surgery to receive a total artificial heart. The device, which can essentially replace an entire human heart for a limited period of time, has only been used fifty-eight times in Canada to date.
June 30, 2022
In January 2022, University of Maryland School of Medicine surgeon-scientists made history by successfully implanting a genetically modified pig heart into a fifty-seven-year-old patient in end-stage heart failure who did not qualify for a traditional heart transplant.
January 11, 2022
On January 10, 2021, the University of Maryland School of Medicine annnounced that Dr. Bartley P. Griffith and his team successfully transplanted a genetically modified pig heart in a 57-year-old man with end-stage heart failure, and the patient was doing well three days later. 
January 11, 2022
On January 10, 2021, the University of Maryland School of Medicine annnounced that Dr. Bartley P.
April 28, 2021
This study assessed the impact of frailty in patients with advanced heart failure on clinical outcomes after heart transplantation (HTx).

Pages